GenVec GenVec is a clinical-stage biopharmaceutical company focusing on developing a pipeline of therapeutics and vaccines through its proprietary AdenoVerse gene delivery platform. | ![]() Dyne Therapeutics Dyne Therapeutics is a biotechnology company which is engaged in the development of targeted therapies for patients with serious muscle diseases. | ![]() Neurogene Neurogene is a biotechnology company which accelerates the development of genetic medicines to people with devastating neurological diseases. | |
Founding Date | Founding Date 1992 | Founding Date 2018 | Founding Date 2018 |
Type | Type Subsidiary | Type Public | Type Private |
Tags | |||
Locations | Locations Gaithersburg, US HQ | Locations Waltham, US HQ | Locations New York, US HQ Houston, US |
Employees | Employees 27 | Employees 1451% decrease | Employees 1091% decrease |
Financial | |||
Net income | Net income ($5.8m) (FY, 2016) | Net income ($446.2m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 2m | Total funding raised $ 165m | Total funding raised $ 68.5m |

Dyne Therapeutics is a biotechnology company which is engaged in the development of targeted therapies for patients with serious muscle diseases.
View company
Neurogene is a biotechnology company which accelerates the development of genetic medicines to people with devastating neurological diseases.
View company